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An estimated 1.5 million new cases of cancer were 
diagnosed in the United States in 2010[1]. With im-
provements in survivorship and the growth and ag-
ing of the U.S. population, the total number of per-
sons living with cancer will continue to increase [2]. 
Despite advances in oncology care, infections remain 
a major cause of morbidity and mortality among 
cancer patients[3-5]. Increased risks for infection are 
attributed, in part, to immunosuppression caused by 
the underlying malignancy and chemotherapy. In ad-
dition patients with cancer come into frequent con-
tact with healthcare settings and can be exposed to 
other patients in these settings with transmissible in-
fections. Likewise, patients with cancer often require 
the placement of indwelling intravascular access de-
vices or undergo surgical procedures that increase 
their risk for infectious complications. Given their 
vulnerable condition, great attention to infection 
prevention is warranted in the care of these patients.
In recent decades, the vast majority of oncology 
services have shifted to outpatient settings, such as 
physician offices, hospital-based outpatient clinics, 
and nonhospital-based cancer centers. Currently, 
more than one million cancer patients receive outpa-
tient chemotherapy or radiation therapy each year[6]. 
Acute care hospitals continue to specialize in the 
treatment of many patients with cancer who are at 
increased risk for infection (e.g., hematopoietic stem 
cell transplant recipients, patients with febrile neu-
tropenia), with programs and policies that promote 
adherence to infection control standards. In contrast, 
outpatient oncology facilities vary greatly in their at-
tention to and oversight of infection control and pre-
vention. This is reflected in a number of outbreaks of 
viral hepatitis and bacterial bloodstream infections 
that resulted from breaches in basic infection preven-
tion practices (e.g., syringe reuse, mishandling of in-
travenous administration sets)[7-10]. In some of these 
incidents, the implicated facility did not have written 
infection control policies and procedures for patient 




A. Intent and Implementation
This document has been developed for outpatient on-
cology facilities to serve as a model for a basic infec-
tion control and prevention plan. It contains policies 
and procedures tailored to these settings to meet min-
imal expectations of patient protections as described 
in the CDC Guide to Infection Prevention in Outpatient 
Settings (available: http://www.cdc.gov/HAI/settings/
outpatient/outpatient-care-guidelines.html). The ele-
ments in this document are based on CDC’s evidence-
based guidelines and guidelines from professional so-
cieties (e.g., Oncology Nursing Society). 
This plan is intended to be used by all outpatient 
oncology facilities. Those facilities that do not have an 
existing plan should use this plan as a starting point to 
develop a facility-specific plan that will be updated and 
further supplemented as needed based on the types of 
services provided. Facilities that have a plan should en-
sure that their current infection prevention policies and 
procedures include the elements outlined in this docu-
ment. While this plan may essentially be used exactly 
“as is,” facilities are encouraged to personalize the plan 
to make it more relevant to their setting (e.g., adding 
facility name and names of specific rooms/locations; 
inserting titles/positions of designated personnel; and 
providing detailed instructions where applicable). 
This plan does not replace the need for an outpatient 
oncology facility to have regular access to an individual 
with training in infection prevention and for that individ-
ual to perform on-site evaluation and to directly observe 
and interact regularly with staff. Facilities may wish to 
consult with an individual with training and expertise in 
infection prevention early on to assist with their infec-
tion control plan development and implementation and 
to ensure that facility design and work flow is conducive 
to optimal infection prevention practices.
B.  Aspects of Care That Are Beyond the Scope of 
This Plan
This model plan focuses on the core measures to pre-
vent the spread of infectious diseases in outpatient on-
cology settings. It is not intended to address facility-
specific issues or other aspects of patient care such as: 
•	 	Infection	prevention	issues	that	are	unique	to	blood	
and marrow transplant centers (a.k.a. bone marrow 
transplant or stem cell transplant centers) 
•	 	Occupational	health	requirements,	including	recom-
mended personal protective equipment for handling 
antineoplastic and hazardous drugs as outlined by 
the Occupational Safety and Health Administration 
and the National Institute for Occupational Safety
•	 	Appropriate	 preparation	 and	 handling	 (e.g.,	 recon-
stituting, mixing, diluting, compounding) of sterile 
medications, including antineoplastic agents
•	 	Clinical	 recommendations	and	guidance	on	appro-
priate antimicrobial prescribing practices and the 
assessment of neutropenia risk in patients undergo-
ing chemotherapy
For more information on these topics, refer to the 
list of resources provided in Appendix D of the plan.
Scope
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Ongoing education and training of facility staff 
are required to maintain competency and ensure 
that infection prevention policies and procedures 
are understood and followed. A list of names of 
designated personnel and their specific roles and 
tasks and contact information is provided in Ap-
pendix A.
1. Education and Training
•	 	All	 facility	 staff,	 including	 contract	 personnel	 (e.g.,	
environmental services workers from an outside 





Standard Precautions represent the minimum infec-
tion prevention measures that apply to all patient care, 
regardless of suspected or confirmed infection status 
of the patient, in any setting where healthcare is de-
livered. These evidence-based practices are designed 
to both protect healthcare personnel and prevent the 
spread of infections among patients. Standard Precau-
tions replaces earlier guidance relating to Universal 
Precautions and Body Substance Isolation. Standard 
Precautions include: 1) hand hygiene, 2) use of personal 
protective equipment (e.g., gloves, gowns, facemasks), 
depending on the anticipated exposure, 3) respiratory 
hygiene and cough etiquette, 4) safe injection prac-
tices, and 5) safe handling of potentially contaminated 
equipment or surfaces in the patient environment.
Transmission-Based Precautions
Transmission-Based Precautions are intended to 
supplement Standard Precautions in patients with 
known or suspected colonization or infection of highly 
transmissible or epidemiologically important patho-
gens. These additional precautions are used when the 
route of transmission is not completely interrupted 
using Standard Precautions. The three categories of 
Transmission-Based Precautions include: 1) Contact 
Precautions, 2) Droplet Precautions, and 3) Airborne 
Precautions. For diseases that have multiple routes of 
transmission, a combination of Transmission-Based 
Precautions may be used. Whether used singly or in 
combination, they are always used in addition to Stan-
dard Precautions. 
The risk of infection transmission and the ability to im-
plement elements of Transmission-Based Precautions 
may differ between outpatient and inpatient settings 
(e.g., facility design characteristics). However, because 
patients with infections are routinely encountered in 
outpatient settings, ambulatory care facilities need to 
develop specific strategies to control the spread of 
transmissible diseases pertinent to their setting. This in-
cludes developing and implementing systems for early 
detection and management of potentially infectious 
patients at initial points of entry to the facility.
For detailed information on Standard and Transmis-
sion-Based Precautions, and summary guidance for 
outpatient settings, refer to the following documents: 
CDC Guide to Infection Prevention in Outpatient Settings 
(available at: http://www.cdc.gov/HAI/settings/outpatient/
outpatient-care-guidelines.html)  
CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
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APIC  Association for Professionals in Infection 
Control and Epidemiology, Inc .
CDC  Centers for Disease Control and 
Prevention
DEA Drug Enforcement Administration
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I . Fundamental Principles of Infection Prevention
II . Education and Training 
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Routine performance of surveillance activities is im-
portant to case-finding, outbreak detection, and im-
provement of healthcare practices. This includes the 
surveillance of infections associated with the care pro-
vided by the facility (defined as healthcare-associated 
infections) and process measures related to infection 
prevention practices (e.g., hand hygiene).
1.  HAI Surveillance 
•	 	Standard	 definitions	 are	 developed	 for	 specific	




•	 	Surveillance	 reports	 are	 prepared	 and	 distributed	
periodically to appropriate personnel for any neces-
sary follow-up actions (e.g., high incidence of certain 
HAIs may prompt auditing of specific procedures or 
a thorough infection control assessment)
2. Disease Reporting
•	 	Facility	 staff	 adhere	 to	 local,	 state	 and	 federal	 re-
quirements for reportable diseases and outbreak re-
porting [see Appendix B].
III . Surveillance and Reporting 
Hand hygiene procedures include the use of alco-
hol-based hand rubs (containing 60-95% alcohol) 
and handwashing with soap and water. Alcohol-
based hand rub is the preferred method for decon-
taminating hands, except when hands are visibly 
soiled (e.g., dirt, blood, body fluids), or after car-
ing for patients with known or suspected infectious 
diarrhea (e.g., Clostridium difficile, norovirus), in 
which case soap and water should be used. Hand 
hygiene stations should be strategically placed to 
ensure easy access.
1. Sample Procedures for Performing Hand Hygiene
 Using Alcohol-based Hand Rub 




and fingers until they are dry (no rinsing is required)




ering all surfaces of hands and fingers
	 •		Rinse	hands	with	water	 and	dry	 thoroughly	with	
paper towel
	 •	Use	paper	towel	to	turn	off	water	faucet
2. Indications for Hand Hygiene
Always perform hand hygiene in the following situations:
•	 	Before	 touching	 a	 patient,	 even	 if	 gloves	 will	 be	
worn
•	 	Before	exiting	the	patient’s	care	area	after	touch-





port, preparing an injection)
•	 	If	hands	will	be	moving	from	a	contaminated-body	
site to a clean-body site during patient care
•	 After	glove	removal
CDC Guideline for Hand Hygiene in Health-Care Settings 
(available at: http://wwwdev.cdc.gov/mmwr/PDF/rr/
rr5116.pdf)
WHO Guidelines on Hand Hygiene in Healthcare 
2009 (available at: http://whqlibdoc.who.int/publica-
tions/2009/9789241597906_eng.pdf) 
IV . Standard Precautions
A. Hand Hygiene 
•	 	Personnel	 providing	 training	 have	 demonstrated	
and maintained competency related to the spe-
cific jobs or tasks for which they are providing in-
struction
•	 	Training	is	provided	at	orientation,	repeated	at	least	
annually and anytime polices or procedures are up-
dated, and is documented as per facility policy
2. Competency Evaluations
•	 	Competency	of	facility	staff	is	documented	initially	and	
repeatedly, as appropriate for the specific job or task 
•	 	Regular	 audits	 of	 facility	 staff	 adherence	 to	 infec-
tion prevention practices (e.g., hand hygiene, envi-
ronmental cleaning) are performed by designated 
personnel 
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B. Personal Protective Equipment
Personal Protective Equipment (PPE) use involves 
specialized clothing or equipment worn by facility 
staff for protection against infectious materials. The 
selection of PPE is based on the nature of the patient 
interaction and potential for exposure to blood, body 
fluids or infectious agents. A review of available PPE 
should be performed periodically (e.g., annually) due 
to new product developments and improvements. 
Please note that this section does not address issues 
related to PPE for the preparation and handling of an-
tineoplastic and hazardous drugs. The recommended 
PPE for those procedures should be determined in ac-
cordance with OSHA and NIOSH. 
1. Use of PPE
Gloves
Wear gloves when there is potential contact with 
blood (e.g., during phlebotomy), body fluids, mucous 
membranes, nonintact skin or contaminated equip-
ment. 
•	 	Wear	gloves	that	fit	appropriately	(select	gloves	ac-
cording to hand size)
•	 	Do	not	wear	the	same	pair	of	gloves	for	the	care	of	





Wear a gown to protect skin and clothing during 
procedures or activities where contact with blood or 
body fluids is anticipated.
•	 	Do	not	wear	 the	 same	gown	 for	 the	care	of	more	
than one patient
•	 	Remove	 gown	 and	 perform	 hand	 hygiene	 before	
leaving the patient’s environment (e.g., exam room)
Facemasks (Procedure or Surgical Masks)
Wear a facemask:
•	 	When	there	is	potential	contact	with	respiratory	se-
cretions and sprays of blood or body fluids (as de-
fined in Standard Precautions and/or Droplet Pre-
cautions)
	 •		May	be	used	in	combination	with	goggles	or	face	
shield to protect the mouth, nose and eyes
•	 	When	placing	 a	 catheter	 or	 injecting	material	 into	
the spinal canal or subdural space (to protect pa-
tients from exposure to infectious agents carried in 
the mouth or nose of healthcare personnel)
	 •		Wear	a	 facemask	to	perform	 intrathecal	chemo-
therapy
Goggles, Face Shields
Wear eye protection for potential splash or spray of 
blood, respiratory secretions, or other body fluids. 
•	 	Personal	eyeglasses	and	contact	lenses	are	not	con-
sidered adequate eye protection
•	 	May	 use	 goggles	 with	 facemasks,	 or	 face	 shield	
alone, to protect the mouth, nose and eyes
Respirators
If available, wear N95-or higher respirators for poten-
tial exposure to infectious agents transmitted via the 
airborne route (e.g., tuberculosis).
•	 	All	healthcare	personnel	that	use	N95-or	higher	res-
pirator are fit tested at least annually and according 
to OSHA requirements











•	 	If	 wearing	 gloves	 in	 combination	 with	 other	 PPE,	
don gloves last
3. Recommendations for Removing PPE
•	 	Remove	PPE	before	 leaving	the	exam	room	or	pa-
tient environment (except respirators which should 























CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
CDC’s tools for personal protective equipment (available: 
http://www.cdc.gov/HAI/prevent/ppe.html)
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To prevent the transmission of respiratory infec-
tions in the facility, the following infection preven-
tion measures are implemented for all potentially 
infected persons at the point of entry and continuing 
throughout the duration of the visit. This applies to 
any person (e.g., patients and accompanying family 
members, caregivers, and visitors) with signs and 
symptoms of respiratory illness, including cough, 
congestion, rhinorrhea, or increased production of 
respiratory secretions. Additional precautions (e.g., 
Transmission-Based Precautions) can be found in 
Section V. 
1.  Identifying Persons with Potential Respiratory 
Infection
•	 	Facility	 staff	 remain	 alert	 for	 any	 persons	 arriving	
with symptoms of a respiratory infection
•	 	Signs	 are	 posted	 at	 the	 reception	 area	 instructing	
patients and accompanying persons to:
	 •		Self-report	 symptoms	 of	 a	 respiratory	 infection	
during registration
	 •		Practice	 respiratory	hygiene	and	cough	etiquette	
(technique described below) and wear facemask 
as needed
2. Availability of Supplies
The following supplies are provided in the reception 
area and other common waiting areas:
•	 	Facemasks,	tissues,	and	no-touch	waste	receptacles	
for disposing of used tissues
•	 Dispensers	of	alcohol-based	hand	rub	
3. Respiratory Hygiene and Cough Etiquette 
All persons with signs and symptoms of a respiratory 
infection (including facility staff) are instructed to:
•	 	Cover	 the	 mouth	 and	 nose	 with	 a	 tissue	 when	




secretions and contaminated objects/materials




tion come at a time when the facility is less crowd-
ed or through a separate entrance, if available
	 •		If	 the	purpose	of	 the	visit	 is	non-urgent,	patients	
are encouraged to reschedule the appointment 
until symptoms have resolved 
	 •		Upon	 entry	 to	 the	 facility,	 patients	 are	 to	 be	 in-
structed to don a facemask (e.g., procedure or sur-
gical mask) 
	 •		Alert	registration	staff	ahead	of	time	to	place	the	
patient in an exam room with a closed door upon 
arrival
•	 If	identified	after	arrival:	
	 •		Provide	 facemasks	 to	 all	 persons	 (including	 per-
sons accompanying patients) who are coughing 
and have symptoms of a respiratory infection
	 •		Place	the	coughing	patient	in	an	exam	room	with	
a closed door as soon as possible (if suspicious 
for airborne transmission, refer to Airborne Pre-
cautions in Section V.D.); if an exam room is not 
available, the patient should sit as far from other 
patients as possible in the waiting room
	 •		Accompanying	persons	who	have	symptoms	of	a	
respiratory infection should not enter patient-care 
areas and are encouraged to wait outside the facility
5.  Healthcare Personnel Responsibilities
•	 	Healthcare	personnel	observe	Droplet	Precautions	
(refer to Section V.C.), in addition to Standard Pre-
cautions, when examining and caring for patients 
with signs and symptoms of a respiratory infection 
(if suspicious for an infectious agent spread by air-
borne route, refer to Airborne Precautions in Sec-
tion V.D.)
•	 	These	precautions	 are	maintained	 until	 it	 is	 deter-
mined that the cause of the symptoms is not an 
infectious agent that requires Droplet or Airborne 
Precautions
•	 	All	 healthcare	 personnel	 are	 aware	 of	 facility	 sick	
leave policies, including staff who are not directly 
employed by the facility but provide essential daily 
services
•	 	Healthcare	 personnel	 with	 a	 respiratory	 infection	
avoid direct patient contact; if this is not possible, 
then a facemask should be worn while providing 
patient care and frequent hand hygiene should be 
reinforced
•	 	Healthcare	personnel	are	up-to-date	with	all	recom-
mended vaccinations, including annual influenza 
vaccine
6. Staff Communication 
•	 	Designated	 personnel	 regularly	 review	 information	
on local respiratory virus activity provided by the 
health department and CDC to determine if the fa-
cility will need to implement enhanced screening for 
respiratory symptoms as outlined in step 7
7.  During Periods of Increased Community 
Respiratory Virus Activity (e.g., Influenza Season)
In addition to the aforementioned infection prevention 
measures, the following enhanced screening measures 
are implemented: 
•	 When	scheduling	and/or	confirming	appointments:
	 •		Pre-screen	 all	 patients	 and	 schedule	 those	 with	
respiratory symptoms to come when the facility 
might be less crowded, if possible
	 •		Instruct	 patients	 with	 respiratory	 symptoms	 to	
don a facemask upon entry to the facility
C. Respiratory Hygiene and Cough Etiquette
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	 •		If	 the	purpose	of	 the	visit	 is	non-urgent,	patients	
with symptoms of respiratory infection are encour-
aged to schedule an appointment after symptoms 
have resolved 
	 •		Encourage	family	members,	caregivers,	and	visitors	
with symptoms of respiratory infection to not ac-
company patients during their visits to the facility
	 •	 	If	possible,	prepare	 in	advance	 for	 the	 registra-
tion staff a daily list of patients with respiratory 
symptoms who are scheduled for a visit 
•	Upon	entry	to	the	facility	and	during	visit:
	 •	 	At	 the	 time	of	patient	 registration,	 facility	 staff	
identify pre-screened patients (from the list) and 
screen all other patients and accompanying per-
sons for symptoms of respiratory infection 
	 •	 	Patients	 identified	 with	 respiratory	 symptoms	
are placed in a private exam room as soon as 
possible; if an exam room is not available, pa-
tients are provided a facemask and placed in a 
separate area as far as possible from other pa-
tients while awaiting care 
	 •	 	If	patient	volume	is	anticipated	to	be	higher	than	
usual with prolonged wait time at registration:
  i.   A separate triage station is established to iden-
tify pre-screened patients (from the list) and 
to screen all other patients and accompany-
ing persons immediately upon their arrival and 
prior to registration
  ii.  Patients identified with respiratory symptoms 
are registered in a separate area, if possible, 
and placed immediately in a private exam 
room; if an exam room is not available, patients 
are provided a facemask and placed in a sepa-
rate area as far as possible from other patients 
while awaiting care 
	 •	 	If	possible,	encourage	family	members,	caregiv-
ers, and visitors with symptoms of respiratory 
infection to not enter the facility 
CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
CDC recommendations for preventing the spread of influen-
za in healthcare settings (available at: http://www.cdc.gov/
flu/professionals/infectioncontrol/healthcaresettings.htm ) 
CDC’s Flu Activity & Surveillance (available at: www.cdc.
gov/flu/weekly/fluactivitysurv.htm)
Injection safety refers to the proper use and handling 
of supplies for administering injections and infusions 
(e.g., syringes, needles, fingerstick devices, intrave-
nous tubing, medication vials, and parenteral solu-
tions). These practices are intended to prevent trans-
mission of infectious diseases between one patient 
and another, or between a patient and healthcare per-
sonnel during preparation and administration of par-
enteral medications. 
To the extent possible, medication preparation 
should take place in pharmacy settings and dedicated 
medication rooms. All staff personnel who use or han-
dle parenteral medications and related supplies should 
be aware of labeling and storage requirements and 
pharmacy standards. Additional recommendations 
for safe injection practices, including the appropriate 
use of single-dose (or single-use) and multi-dose vi-
als and the proper technique for accessing intravascu-
lar devices, can be found in Section IV.E. (Medication 
Storage and Handling), in Section VI (Central Venous 
Catheters), respectively, as well as in Appendix D.
1. General Safe Injection Practices
•	 	Use	aseptic	technique	when	preparing	and	admin-
istering chemotherapy infusions or other parenteral 
medications (e.g., antiemetics, diphenhydramine, 
dexamethasone)
•	 	Whenever	possible,	use	commercially	manufactured	
or pharmacy-prepared prefilled syringes (e.g., saline 
and heparin)
•	 	Avoid	prefilling	and	storing	batch-prepared	syringes	
except in accordance with pharmacy standards
•	 	Avoid	unwrapping	syringes	prior	to	the	time	of	use
•	 	Never	administer	medications	from	the	same	syringe	
to multiple patients, even if the needle is changed or 
the injection is administered through an intervening 




single-use vials, ampoules, or bags or bottles of in-
travenous solution to more than one patient (e.g, do 
not use a bag of saline as a common source supply 
for multiple patients)
•	 	Cleanse	the	access	diaphragms	of	medication	vials	
with 70% alcohol and allow the alcohol to dry before 
inserting a device into the vial 
•	 	Dedicate	multi-dose	vials	to	a	single	patient	when-
ever possible. If multi-dose vials must be used for 
more than one patient, they are restricted to a dedi-
cated medication preparation area and should not 
enter the immediate patient treatment area (e.g., 
exam room, chemotherapy suite) 
•	 	Dispose	of	used	syringes	and	needles	at	the	point	of	
use in a sharps container that is closable, puncture-
resistant, and leak-proof
•	 	Do	not	use	fluid	infusion	or	administration	sets	(e.g.,	
intravenous tubing) for more than one patient
•	 	Use	single-use,	disposable	fingerstick	devices	(e.g.,	
lancets) to obtain samples for checking a patient’s 
blood glucose, PT/INR, etc. and dispose of them af-
ter each use; do not use a lancet holder or penlet 
D. Injection Safety
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device for this purpose
•	 	Adhere	 to	 federal	 and	 state	 requirements	 for	pro-
tection of healthcare personnel from exposure to 
bloodborne pathogens
2.  Spinal Injection Procedures
•	 	Use	 aseptic	 technique	 and	 follow	 safe	 injection	
practices (e.g., dedicating single-dose vials to sin-
gle-patient use) 
•	 	At	a	minimum,	wear	a	facemask	(e.g.,	procedure	or	
surgical masks) and sterile gloves when injecting 
material or inserting a catheter into the epidural or 
subdural space (e.g., administration of intrathecal 
chemotherapy) 
•	 	For	 other	 spinal	 procedures	 (e.g.,	 diagnostic	 and	
therapeutic lumbar punctures) or handling of devic-
es to access the cerebrospinal fluid (e.g., Ommaya 
reservoir):
	 •	 	At	a	minimum,	use	aseptic	technique	and	follow	
safe injection practices 
	 •	 	Facemask	 can	 be	 considered	 as	 an	 additional	
precaution
3. Phlebotomy Procedures
•	 	Phlebotomy	 procedures	 are	 performed	 in	 a	 dedi-
cated area, if possible
•	 	If	 the	 procedure	 has	 to	 be	 done	 elsewhere	 (e.g.,	
exam room, chemotherapy suite), do not bring com-
mon trays of supplies for phlebotomy or intravenous 
device access to the patient’s immediate treatment 
area; bring only the necessary supplies to the pa-
tient side 
•	 	Hand	hygiene	stations	(e.g.,	alcohol-based	hand	rub	






phlebotomist to ensure easy access and safe dis-




	 •	 	Avoid	 placing	 tubes	 on	 patient	 charts	 or	 oth-
er items or surfaces that cannot be properly 
cleaned
	 •	 	Do	not	process	or	 store	blood	 specimens	near	
medications or medication preparation area
CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
CDC Clinical Reminder: Spinal Injection Procedures Per-
formed without a Facemaks Pose Risk for Baterial Menin-
gitis (available at: http://www.cdc.gov/injectionsafety/PDF/
Clinical_Reminder_Spinal-Infection_Meningitis.pdf) 
The measures outlined in this section pertain to the 
general storage and handling of parenteral medica-
tions outside of the pharmacy setting. The appro-
priate storage and handling (e.g., reconstituting, 
mixing, diluting, compounding) of antineoplastic 
drugs and other sterile medications that typically 
require preparation in pharmacy settings should be 
determined in accordance with established official 
and enforceable standards for these activities (e.g., 
ensuring appropriate environmental and engineer-
ing controls such as biological safety cabinets and 
laminar airflow hoods, and proper use of aseptic 
technique), including those of the United States 
Pharmacopeia and the Food and Drug Administra-
tion. These functions are performed by personnel 
who have the appropriate qualifications and train-
ing as determined in accordance with the state 
pharmacy board. Consultation with the state phar-
macy board and oncology pharmacy specialists is 
recommended.
In general, parenteral medication storage, handling, 
and administration should adhere to injection safety 
measures as outlined in Section IV.D. (Injection Safe-
ty). Parenteral medications include single-dose and 
multi-dose vials, ampoules, bags or bottles of intrave-
nous fluids. 
Single-dose vials (or single-use vials) are intended for 
use in a single patient for a single case/procedure/in-
jection. Single-dose or single-use vials are labeled as 
such by the manufacturer and typically lack an antimi-
crobial preservative.
Multi-dose vials contain more than one dose of medi-
cation. They are labeled as such by the manufacturer 
and typically contain an antimicrobial preservative to 
help prevent the growth of bacteria. However, this pre-
servative has no effect on viruses and does not fully 
protect against contamination when safe injection 
practices are not followed.
1. Medication Storage
•	 	Store	 all	 medications	 (e.g.,	 granulocyte-colony	
stimulating factors, injectable hormonal agents) in 
accordance with manufacturer’s instructions (e.g., 
shelf-life, temperature)
•	 Use	of	freezers/refrigerators	
	 •	 	Store	 medications	 that	 require	 refrigeration	 in	
a dedicated, labeled refrigerator that meets re-
quirements for such storage (e.g., thermostat 
control, separate exterior door for refrigerator 
and freezer compartments) 
	 •	 	Designated	personnel	maintain	temperature	log	
E. Medication Storage and Handling
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(monitor temperature at least twice daily for 
vaccine storage) and ensure alternative storage 
method is in place in the event of power or re-
frigerator failure
•	 	Multi-dose	vials	are	stored	in	the	Medication	Room	
and not in the immediate patient treatment area 
(e.g., exam room, chemotherapy suite)
2. Medication Preparation
•	 	Draw	 up	 medications	 in	 the	 Medication	 Room	 or	
in a designated clean area that is free of any items 
potentially contaminated with blood or body fluids 
(e.g., used equipment such as syringes, needles, IV 
tubing, blood collection tubes, and needle holders)
•	 	Note: Multi-dose vials should not be accessed in the 
immediate patient treatment area (e.g., exam room, 
chemotherapy suite); if a multi-dose vial enters the 
immediate patient-care area, it should be dedicated 
to that patient and discarded after use
•	 	Note: Bags or bottles of intravenous solution (e.g., 




	 	 •	 	Perform	 hand	 hygiene	 before	 handling	 the	
medication
	 	 •	 	Disinfect	the	rubber	septum	with	alcohol	and	
allow the alcohol to dry prior to piercing
	 	 •	 	Always	 use	 a	 new	 sterile	 syringe	 and	 sterile	
needle to draw up the medication; be careful 
to avoid contact with the non-sterile environ-
ment during the process
	 	 •	 	Never	leave	a	needle	inserted	into	the	septum	
of a medication vial for multiple draws
	 	 •	 	Ensure	that	any	device	 inserted	 into	the	sep-
tum (e.g., chemotherapy dispensing pins) are 
used in accordance with manufacturer’s in-
structions and they do not compromise the 
integrity of the remaining vial contents
	 	 •	 	Minimize	multiple	entries	into	bags	of	fluid	to	add	
medications; if more than one entry is required, 
always use a new sterile syringe and sterile nee-
dle and access the bag using aseptic technique
3. When to Discard Medications
•	 	Medications	 should	 always	 be	 discarded	 accord-
ing to the manufacture’s expiration date (even if not 
opened) and whenever sterility is compromised or 
questionable
•	 	For	single-dose	vials	that	have	been	opened	or	ac-
cessed (e.g., needle-puncture), the vial should be 
discarded according to the time the manufacturer 
specifies for the opened vial or at the end of the 
case/procedure for which it is being used, whichever 
comes first. It should not be stored for future use.
•	 	For	multidose	vials	 that	 have	been	opened	or	 ac-
cessed (e.g., needle-punctured), the vials should 
be dated and discarded within 28 days unless the 
manufacturer specifies a different (shorter or lon-
ger) date for that opened vial
CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
CDC FAQs Regarding Safe Practices for Medical Injections 
(available at: http://www.cdc.gov/injectionsafety/providers/
provider_faqs.html) 
CDC Vaccine Storage and Handling Toolkit (available at: 
http://www2a.cdc.gov/vaccines/ed/shtoolkit/) 
F.  Cleaning and Disinfection of Devices and Environmental Surfaces
The procedures outlined in this section pertain to the 
cleaning and disinfection of noncritical patient-care 
devices (e.g., blood pressure cuff) and environmental 
surfaces in patient-care areas (e.g., exam rooms) and 
certain common-use areas (e.g., bathrooms). 
Standard procedures and recommended practices 
for cleaning and disinfecting compounding areas (e.g., 
pharmacy settings) and the handling, transporting, and 
disposing of antineoplastic agents should be determined 
in accordance with local, state, and federal authorities, 
including state board of pharmacy, USP, FDA, and DEA. 
1. Designated Personnel
•	 	Responsibilities	for	cleaning	and	disinfection	of	en-
vironmental surfaces and medical equipment are 
assigned to specific personnel (as indicated in Ap-
pendix B)
	 •	 	If	Environmental	Services	are	only	available	after-
hours (e.g., contractors from outside agency), 
then designated facility staff are assigned spe-
cific responsibilities for cleaning and disinfection 
during clinic hours
•	 	All	assigned	personnel	are	trained	in	the	appropri-
ate cleaning/disinfection procedures and the proper 
use of PPE and cleaning products 
2. Supplies and Cleaning Products
•	 	Designated	 personnel	 regularly	 restock	 necessary	
supplies (e.g., gloves, gowns, facemasks) and re-
plenish dispensers of alcohol-based hand rub and 
soap throughout the facility
•	 	Follow	manufacturer’s	instructions	for	cleaning	sur-
faces and noncritical devices; ensure that the clean-
ing product used is compatible with the surface/
device being cleaned
•	 	Use	 EPA-registered	 disinfectant	 with	 appropriate	
germicidal claim for the infective agent of concern 
(may vary depending on situation) and follow the 
manufacturer’s safety precautions and instructions 
(e.g., amount, dilution, safe use, storage and dispos-
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al) for cleaning/disinfection
•	 	Products	 and	 supplies	 are	 reviewed	 periodically	
(e.g., annually) due to product developments and 
improvements and to ensure that the materials used 
are consistent with existing guidelines and meet the 
needs of the staff
•	 	If	reusable	mops	and	cleaning	cloths	are	used,	these	
are cleaned after use and allowed to dry before reuse
3. Frequency of Cleaning
Patient-care areas, medication preparation areas (out-
side pharmacy/compounding areas), and bathrooms 
are cleaned at least daily, with the following exceptions:
•	 	Promptly	 clean	 and	 decontaminate	 any	 location	
with spills of blood and other potentially infectious 
materials (refer to step 7 below)
•	 	Clean	 medication	 preparation	 areas	 when	 visibly	
soiled; if medication preparation takes place in the 
patient treatment area (outside a designated medi-
cation room), clean this area after each patient en-
counter:
	 	 •	 	Ensure	the	medication	preparation	area	is	free	
of any items contaminated with blood or body 
fluids (e.g., used equipment such as syringes, 
needles, IV tubing, blood collection tubes, and 
needle holders)
•	 	Disinfect	 bathrooms	 after	 use	 by	 a	 patient	 with	
known or suspected infectious diarrhea and before 
use by another person (refer to step 5 below)
•	 	Disinfect	environmental	surfaces	and	noncritical	pa-
tient-care devices when visibly soiled 
•	 	Disinfect	environmental	surfaces	and	noncritical	pa-
tient-care devices in between patient use if:
	 •	 	There	was	 direct	 contact	 to	 non-intact	 skin	 or	
mucous membrane or potential contamination 
with body fluids (e.g., blood, secretions)
	 •	 	The	patient-care	device	involves	a	blood	glucose	
meter or other point of care testing device (e.g., 
PT/INR readers) that utilizes blood samples; to 
prevent bloodborne pathogen transmission, 
these devices must be cleaned and disinfected 
after each use in accordance with manufactur-
er’s instructions
4. Cleaning Patient-Care Areas 
General cleaning and disinfection measures that apply 
to any patient-care area:
•	 Wear	appropriate	PPE
•	 	In	general,	cleaning	should	be	performed	before	dis-
infection unless a one-step detergent disinfectant is 
used
•	 	Wet-dust	horizontal	surfaces	by	moistening	a	cloth	
with a small amount of an EPA-registered disinfectant
•	 	Avoid	 dusting	 methods	 that	 disperse	 dust	 (e.g.,	
feather-dusting)
•	 	Concentrate	on	cleaning	high-touch	surfaces	(areas	
frequently touched by patients and facility staff) 
and those in close proximity to the patient, as out-
lined below for specific rooms/areas
•	 	Follow	manufacturer’s	instructions	for	cleaning	and	
maintaining noncritical medical device/equipment 
•	 	Clean	walls,	blinds,	and	window	curtains	when	they	
are visibly dusty or soiled




lows between patient use
•	 	Place	any	used	linens	(e.g.,	exam	gowns,	sheets)	in	a	
designated container located in each exam room af-
ter each patient use; refer to step 8 below for laun-
dering soiled linens
•	 	Clean	 any	medication	 preparation	 area	 after	 each	
patient encounter and ensure contaminated items 
(as described above) are not placed in or near the 
area
•	 	Focus	 cleaning	 on	 high-touch	 surfaces	 (at	 least	
daily), e.g., exam bed, bedrails, blood pressure cuff, 
stethoscope, wall-mounted ophthalmoscope and 
otoscope (per manufacturer’s instructions), chair 
and bedside stool, and door knob
•	 	Decontaminate	high-touch	surfaces	using	an	EPA-
registered disinfectant with specific claim labels for 
the infective agent
	 •	 	If	patient	has	suspected	infectious	diarrhea	and	
the infective agent is unknown, clean high-touch 
surfaces using a sodium hypochlorite (bleach)-
based product (e.g., 1:10 dilution prepared fresh)
Chemotherapy Suites
•	 	Clean	patient	chair,	IV	poles/pumps,	and	side	table	
between each patient use
•	 	Clean	any	medication	preparation	area	after	each	pa-
tient encounter and ensure contaminated items (as 
described above) are not placed in or near the area
Triage Stations and/or Locations for Performing 
Vital Signs (if not done in exam rooms)
•	 	Focus	cleaning	on	high-touch	surfaces	(at	least	dai-
ly): patient chair, blood pressure cuff, pulse oximetry 
sensors (follow manufacturer’s instructions), ther-
mometers (if disposable oral temperature probes 
are used, they should be discarded after each use)
Phlebotomy Stations
•	 	Focus	cleaning	on	high-touch	surfaces	(at	least	dai-
ly): patient chair and arm rest, procedure table
•	 	Promptly	clean	and	disinfect	surfaces	contaminated	
by blood using an EPA-registered disinfectant with 
specific label claims for bloodborne pathogens (e.g, 






and faucet handles at least daily, and the walls if vis-
ibly soiled
•	 	If	used	by	a	patient	with	known	or	suspected	infec-
tious diarrhea, clean the bathroom before it is used 
again, focusing on the toilet and the area around the 
toilet:
	 •	 	Use	an	EPA-registered	disinfectant	with	specific	
claim labels for the infective agent 
	 •	 	If	infective	agent	is	unknown,	use	a	bleach-based	
disinfectant (e.g., 1:10 dilution prepared fresh)
6. Cleaning Medication Rooms (excluding pharmacy 
settings or locations where sterile compounding is 
performed; for these locations, refer to the state 
pharmacy board and USP recommendations)
•	 Wear	appropriate	PPE
•	 	Clean	the	countertops	and	surfaces	where	medica-
tion preparation occurs at least daily and when vis-
ibly soiled
•	 	Ensure	 contaminated	 items	 (as	 described	 above)	
are not placed in or near the medication prepara-
tion area
•	 	Refrigerators	 for	 storing	 medications	 are	 cleaned	
at defined intervals and when soiled, in accordance 
with manufacturer’s instructions
7. Cleaning Spills of Blood and Body Substances
•	 	Wear	 protective	 gloves	 and	 use	 appropriate	 PPE	
(e.g., use forceps to pick up any sharps and discard 
in sharps container)
•	 	If	the	spill	contains	large	amounts	of	blood	or	body	
fluids (e.g., >10 mL), clean the visible matter with 
disposable absorbent material and discard in appro-
priate containers for biohazardous waste
•	 	Decontaminate	 the	 area	 using	 an	 EPA-registered	
disinfectant with specific label claims for blood-
borne pathogens (e.g., HIV, HBV, HCV) or a freshly 
diluted bleach-based product (preferably EPA-reg-
istered), in accordance with manufacturer’s instruc-




	 •	 	If	 the	 spill	 involves	 large	 amounts	 of	 blood	 or	
body fluids, use a 1:10 dilution for first application 
of germicide before cleaning, then followed by 
cleaning and subsequent decontamination with 
1:100 dilution application 
8. Handling and Laundering Soiled Linens
•	 	Handle	all	 contaminated	 linens	with	minimum	agi-
tation to avoid contamination of air, surfaces, and 
persons
•	 	Do	not	sort	or	rinse	soiled	linens	in	patient-care	areas
•	 	Use	 leak-resistant	containment	 for	 linens	contami-
nated with blood or body substances; ensure that 
there is not leakage during transport
•	 	If	laundry	chutes	are	used,	ensure	that	laundry	bags	
are closed before tossing the filled bag into the 
chute; do not place loose items in the laundry chute
•	 	In	 the	 laundry	 area,	 appropriate	PPE	 (e.g.,	 gloves)	
are worn by laundry personnel while sorting soiled 
linen, and hand hygiene supplies are available for 
their use
•	 	If	 laundry	 equipment	 is	 available	 on	 premise,	 use	
and maintain the equipment according to manufac-
turer’s instructions 
	 •	 	In	general,	 If	hot-water	laundry	cycles	are	used,	
wash with detergent in water ≥160°F (≥71°C) for 
≥25 minutes 
	 •	 	If	low-temperature	(<160°F	[<70°C])	laundry	cy-
cles are used, wash with proper concentrations 
of laundry chemicals that are suitable for low-
temperature washing 
•	 	If	commercial	laundry	facilities	are	used,	ensure	that	




located in every patient-care area (e.g., exam room, 
chemotherapy suite, phlebotomy station)
	 •	 	Specifically	 for	 phlebotomy	 stations,	 a	 sharps	
container is located within a short distance of 
each phlebotomist’s work space
	 •	 	All	 sharps	 are	 disposed	 of	 in	 the	 designated	
sharps container; do not bend, recap, or break 
used syringe needles before discarding them 
into the container
	 •	 	Filled	sharps	containers	are	disposed	of	in	accor-
dance with state regulated medical waste rules
•	 	Regular	 trash	 and	 regulated	 medical	 waste	 (e.g.,	
biohazardous material and chemical hazardous 
waste, including antineoplastic drugs) are disposed 
of in their designated containers
•	 	All	trash	and	waste	containers	are	emptied	at	least	
daily by designated personnel
	 •	 Wear	appropriate	PPE
	 •	 	Handle,	transport,	and	dispose	regulated	waste,	
including antineoplastic and hazardous drugs, in 
accordance with state and local regulations
CDC Guidelines for Environmental Infection Control in 
Health-Care Facilities (available at: http://www.cdc.gov/
hicpac/pdf/guidelines/eic_in_HCF_03.pdf )
CDC Guideline for Disinfection and Sterilization in Health-
care Facilities, 2008 (available at: http://www.cdc.gov/
hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf) 
CDC Guideline for the Prevention and Control of Norovirus 
Gastroenteritis Outberaks in Healthcare Settings (available 
at: http://www.cdc.gov/hicpac/pdf/norovirus/Norovirus-
Guideline-2011.pdf)
CDC Infection Prevention during Blood Glucose Monitoring 
and Insulin Administration (available at: http://www.cdc.gov/
injectionsafety/blood-glucose-monitoring.html) 
APIC Infection Prevention Manual for Ambulatory Care, 2009
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In addition to consistent use of Standard Precautions, 
additional precautions may be warranted in certain 
situations as described below. 
•	 	Facility	 staff	 remain	 alert	 for	 any	 patient	 arriving	
with symptoms of an active infection (e.g., diarrhea, 




come at a time when the facility is less crowded, 
if possible
	 •	 	Alert	registration	staff	ahead	of	time	to	place	
the patient in a private exam room upon arriv-
al if available and follow the procedures perti-
nent to the route of transmission as specified 
below
	 •	 	If	the	purpose	of	the	visit	is	non-urgent,	patients	
are encouraged to reschedule the appointment 




tients with norovirus, rotavirus, or Clostridium 
difficile), draining wounds, uncontrolled secre-
tions, pressure ulcers, or presence of ostomy 
tubes and/or bags draining body fluids 
	 •	 Presence	of	generalized	rash	or	exanthems	
•	 	Prioritize	placement	of	patients	in	an	exam	room	if	they	
have stool incontinence, draining wounds and/or skin le-
sions that cannot be covered, or uncontrolled secretions
•	 	Perform	hand	hygiene	before	touching	patient	and	
prior to wearing gloves
•	 PPE	use:	
	 •	 	Wear	gloves	when	touching	the	patient	and	the	
patient’s immediate environment or belongings
	 •	 	Wear	a	gown	if	substantial	contact	with	the	pa-
tient or their environment is anticipated
•	 	Perform	hand	hygiene	after	 removal	of	PPE;	note: 
use soap and water when hands are visibly soiled 
(e.g., blood, body fluids), or after caring for patients 




•	 	Instruct	 patients	 with	 known	 or	 suspected	 infec-
tious diarrhea to use a separate bathroom, if avail-
able; clean/disinfect the bathroom before it can be 
used again (refer to Section IV.F.5. for bathroom 
cleaning/disinfection)
V . Transmission-Based Precautions
A. Identifying Potentially Infectious Patients 
B. Contact Precautions
•	 	Apply	 to	 patients	 known	 or	 suspected	 to	 be	 in-
fected with a pathogen that can be transmitted by 
droplet route; these include, but are not limited to:
	 •	 	Respiratory	viruses	(e.g.,	influenza,	parainfluenza	
virus, adenovirus, respiratory syncytial virus, hu-
man metapneumovirus)
	 •	 Bordetella	pertusis
	 •	 	For	first	24	hours	of	therapy:	Neisseria meningiti-
des, group A streptococcus 
•	 	Place	 the	 patient	 in	 an	 exam	 room	with	 a	 closed	
door as soon as possible (prioritize patients who 
have excessive cough and sputum production); if an 
exam room is not available, the patient is provided a 
facemask and placed in a separate area as far from 
other patients as possible while awaiting care.
•	 PPE	use:	
	 •	 	Wear	a	facemask,	such	as	a	procedure	or	surgi-
cal mask, for close contact with the patient; the 
facemask should be donned upon entering the 
exam room
	 •	 	If	substantial	spraying	of	respiratory	fluids	is	an-
ticipated, gloves and gown as well as goggles (or 
face shield in place of goggles) should be worn
•	 	Perform	hand	hygiene	before	and	after	touching	the	
patient and after contact with respiratory secretions 
and contaminated objects/materials; note: use soap 
and water when hands are visibly soiled (e.g., blood, 
body fluids)
•	 	Instruct	patient	to	wear	a	facemask	when	exiting	the	
exam room, avoid coming into close contact with 
other patients, and practice respiratory hygiene and 
cough etiquette
•	 	Clean	and	disinfect	the	exam	room	accordingly	(re-
fer to Section IV.F.4.)
 C. Droplet Precautions 
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The procedures outlined below pertain to the access 
and maintenance of long-term central venous cath-
eters (e.g., vascular access devices). These include pe-
ripherally inserted central catheters (PICCs), tunneled 
catheters (e.g., Broviac®, Hickman®, and Groshong® 
catheters), including tunneled apheresis catheters, 
and implanted ports. For other types of access de-
vices, such as intraperitoneal ports, refer to guidelines 
from relevant professional societies (e.g., Oncology 
Nursing Society).
Several recommendations in this section have been 
adapted directly from the Oncology Nursing Society 
Access Devices Guidelines and the Infusion Nursing 
Society Standards of Practice. There is not a consen-
sus over the use of clean versus sterile gloves when 
accessing certain vascular access devices, such as 
implanted ports; where indicated, recommendations 
by specific professional societies are provided. While 
the recommendations below apply generally, health-
care personnel are to follow manufacturers’ instruc-
tions and labeled use for specific care and mainte-
nance. Only healthcare personnel who have attained 
and maintained competency should perform these 
procedures.
•	 		Apply	 to	 patients	 known	 or	 suspected	 to	 be	 in-
fected with a pathogen that can be transmitted by 




	 •	 	Localized	 (in	 immunocompromised	 patient)	 or	
disseminated herpes zoster (until lesions are 
crusted over)
•	 	Have	patient	 enter	 through	a	 separate	entrance	 to	
the facility (e.g., dedicated isolation entrance), if 
available, to avoid the reception and registration area
•	 	Place	the	patient	immediately	in	an	airborne	infec-
tion isolation room (AIIR)
•	 If	an	AIIR	is	not	available:
	 •	 	Provide	a	 facemask	 (e.g.,	procedure	or	 surgical	
mask) to the patient and place the patient im-
mediately in an exam room with a closed door
	 •	 	Instruct	 the	 patient	 to	 keep	 the	 facemask	 on	
while in the exam room, if possible, and to change 
the mask if it becomes wet
	 •	 	Initiate	protocol	 to	 transfer	patient	 to	 a	 health-
care facility that has the recommended infection-
control capacity to properly manage the patient
•	 PPE	use:	
	 •	 	Wear	 a	 fit-tested	 N-95	 or	 higher	 level	 dispos-
able respirator, if available, when caring for the 
patient; the respirator should be donned prior to 
room entry and removed after exiting room
	 •	 	If	substantial	spraying	of	respiratory	fluids	is	an-
ticipated, gloves and gown as well as goggles or 
face shield should be worn
•	 	Perform	hand	hygiene	before	and	after	touching	the	
patient and after contact with respiratory secretions 
and/or body fluids and contaminated objects/mate-
rials; note: use soap and water when hands are vis-
ibly soiled (e.g., blood, body fluids)
•	 	Instruct	 patient	 to	 wear	 a	 facemask	 when	 exiting	
the exam room, avoid coming into close contact 
with other patients , and practice respiratory hy-
giene and cough etiquette
•	 	Once	the	patient	leaves,	the	exam	room	should	re-
main vacant for generally one hour before anyone 
enters; however, adequate wait time may vary de-
pending on the ventilation rate of the room and 
should be determined accordingly* 
	 •	 	If	staff	must	enter	the	room	during	the	wait	time,	
they are required to use respiratory protection
*Francis J. Curry National Tuberculosis Center, FAQ: “How 
long does it take to clear the air in an isolation or high-risk 
procedure room?” (Available at: http://www.flpic.com/TB_
air_exchange.pdf) 
CDC 2007 Guideline for Isolation Precautions (available at: 
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf) 
CDC Guidelines for Preventing the Transmission of Myco-
bacterium tuberculosis in Health-Care Settings, 2005 (Avail-
able at: http://www.cdc.gov/mmwr/pdf/rr/rr5417.pdf)
1. Accessing Central Venous Catheters 
This procedure applies only to PICCs and tunneled 
catheters, including apheresis catheters. Refer to Part 
D.1. below for accessing implanted ports. In general, 
closed catheter access systems should be used pref-






with an appropriate antiseptic (e.g., chlorhexidine, povi-
done iodine, or 70% alcohol), and allow to dry (if povi-
done iodine is used, it should dry for at least 2 minutes) 
D. Airborne Precautions
A.  General Maintenance and Access Procedures
VI . Central Venous Catheters 
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•	 	Access	the	injection	cap	with	the	syringe	or	IV	tub-
ing (opening the clamp, if necessary) 
•	 Perform	hand	hygiene	when	done






catheter as flushing is completed, if necessary) and 
promptly dispose of used syringe(s)
•	 Perform	hand	hygiene	when	done
3. Flushing Technique
Refer to the manufacturer’s instructions of the cath-
eter and the needleless connector for the appropriate 
technique to use; unless otherwise specified, perform 
the following:
•	 	Single-use	flushing	systems	(e.g.,	single-dose	vials,	




size to flush, preferably use 10 mL 
•	 	Flush	the	catheter	vigorously	using	pulsating	tech-
nique and maintain pressure at the end of the flush 
to prevent reflux
	 •	 	Positive	 pressure	 technique	 (may	 not	 apply	 to	
neutral-displacement or positive-displacement 
needleless connectors): 
  i.  Flush the catheter, continue to hold the plung-
er of the syringe while closing the clamp on 
the catheter and then disconnect the syringe
  ii.  For catheters without a clamp, withdraw the 
syringe as the last 0.5-1 mL of fluid is flushed
	 •	 Promptly	dispose	of	used	syringe(s)
•	 Perform	hand	hygiene	when	done
4. Changing Catheter Site Dressing
This procedure applies only to PICCs and tunneled 
catheters, including apheresis catheters.
•	 	Supplies	 for	 site	 cleansing	 and	 dressing	 changes	
should be single-use; refer to manufacturer’s rec-





per Infusion Nursing Society includes use of face-
masks and sterile gloves)
•	 	Remove	existing	dressing	and	inspect	the	site	visually	
•	 	Apply	antiseptic	to	the	site	using	>0.5%	chlorhexi-
dine preparation with alcohol; if there is contrain-
dication to chlorhexidine, use tincture of iodine, an 
iodophor, or 70% alcohol as alternative 
•	 	Do	not apply topical antibiotic ointment or creams 
to catheter site
•	 	Cover	with	either	sterile	gauze	or	sterile,	transparent,	
semipermeable dressing (refer to catheter-specific 
recommendations for frequency of dressing changes)
•	 Perform	hand	hygiene	when	done
5. Changing the Injection Cap (e.g., Needleless 
Connector)
This procedure applies only to PICCs and tunneled 
catheters, including apheresis catheters. Refer to man-
ufacturer’s instructions for how frequently to change 
the injection cap; if information is not available, in gen-
eral, change every week or when there are signs of 
blood, precipitate, cracks, leaks, or other defects, or 






propriate antiseptic agent; clamp the catheter if 
necessary as cap is removed
•	 	Attach	 new	 cap	 to	 catheter	 hub	 using	 aseptic	
technique
•	 Perform	hand	hygiene	when	done
Refer to steps 1-5 in Section VI.A. above for PICC 
access and common maintenance procedures. Ad-





less soiled or loose
	 •	 	Gauze	dressing:	change	every	2	days	or	as	need-
ed if wet, soiled, or nonocclusive
•	 	Flushing:	 use	 of	 heparin	 flushes	 and	 the	 recom-
mended concentration and frequency of flushing 
are determined in accordance with manufacturer’s 
instructions and per the treating clinician’s orders (in 
general, for valve catheters or closed tip catheters, 
flush with normal saline unless otherwise specified)
B.  Peripherally Inserted Central Catheters (PICCs)
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1. Port Access Procedure
•	 	Perform	hand	hygiene	first;	prior	to	each	access,	ex-
amine the site for complications, including exami-
nation of the veins of the chest and neck to look 
for any swelling, erythema, drainage or leakage, or 
presence of pain, discomfort, or tenderness
•	 	Palpate	the	outline	of	the	portal	body
•	 	Perform	hand	hygiene	again;	wear	 clean	or	 sterile	
gloves (additional precaution per INS includes use 




coring needle (e.g., Huber needle) with the other 




or stabilization device; apply gauze and tape for 
short-term use (such as for outpatient treatment) 
•	 Perform	hand	hygiene	when	done
2. Port De-access Procedure
•	 Perform	hand	hygiene;	wear	clean	or	sterile	gloves
•	 Remove	dressing	and	inspect	site
•	 	Remove	 gloves,	 perform	 hand	 hygiene	 again,	 and	
wear new gloves
•	 	Flush	device	with	20	mL	normal	saline	followed	by	
heparin flush, unless otherwise specified by manu-
facturer and/or treating clinician
•	 	Stabilize	 port	 with	 one	 hand,	 and	 remove	 needle	
with the other hand; maintain positive pressure 
while deaccessing by flushing the catheter while 




3. Maintenance and Care
•	 	For	 short-term	 use	 in	 outpatient	 settings,	 a	 light	
dressing may be used in place of an occlusive dress-
ing during the infusion; ensure the needle is secure 
in the portal septum as described above
•	 	Use	 of	 heparin	 flushes	 and	 the	 recommended	
concentration and frequency of flushing are to be 
determined in accordance with manufacturer’s in-
structions and per the treating clinician’s order (in 
general, when not in use, implanted ports should be 
accessed and flushed every 4-8 weeks to maintain 
patency)
•	 	For	blood	specimens:	discard	5-10	mL	of	blood,	ob-
tain specimen, flush with 10-20 mL of normal saline, 
and promptly discard used syringe(s)
ONS Access Device Guidelines, Recommendations for 
Nursing Practice and Education, Vascular Access Devices 
chapter, 3rd edition, 2011
INS 2011 Infusion Nursing Standards of Practice 
CDC Guidelines for the Prevention of Intravascular Catheter-
Related Infections, 2011 (available at: http://www.cdc.gov/
hicpac/pdf/guidelines/bsi-guidelines-2011.pdf) 
D. Implanted Ports
Tunneled catheters include Broviac®, Hickman®, and 
Groshong® catheters, as well as apheresis catheters. 
Refer to steps 1-5 in Section VI.A. above for catheter 
access and common maintenance procedures. Addi-




	 •	 	Transparent	 dressing:	 change	 not	 more	 than	
once a week unless soiled or loose
	 •	 	Gauze	and	tape	dressing:	change	every	2	days	or	
as needed if wet, soiled, or nonocclusive
	 •	 	Once	healed,	tunneled	catheters	may	go	without	
a dressing unless the patient is immunocompro-
mised
•	 	Flushing:	 use	 of	 heparin	 flushes	 and	 the	 recom-
mended concentration and frequency of flushing 
are determined in accordance with manufacturer’s 
instructions and per the treating clinician’s orders 
(in general, for Groshong® catheters, valve cathe-













































































a Several roles/tasks may be performed by the same person, e.g., Infection Prevention personnel, or by more than one person.
b  Cleaning/disinfection of spills of blood or other potentially infectious materials should be assigned to personnel trained to handle 
such situation; this may include facility staff other than ES/housekeeping staff.
c  Ensure this task is assigned to personnel who are available to respond in a timely manner; in some facilities, ES/housekeeping staff 
may be better equipped to handle this type of cleaning/disinfection. 
  
Appendix	A.
Example List of Contact Persons and Roles/Responsibilities 
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[Insert a list of reportable disease/conditions specific 
to your state and the appropriate contact information 
for your local and state health authorities. This informa-
tion may be found at your state department of health 
website and/or at the following weblink: http://www.
cste.org/dnn/ProgramsandActivities/PublicHealthIn-
formatics/PHIStateReportableWebsites/tabid/136/




 The Infection Prevention Checklist for Outpatient Set-
tings is a companion to the CDC Guide to Infection 
Prevention for Outpatient Settings: Minimum Expecta-
tions for Safe Care and can be accessed at the follow-
ing weblink: http://www.cdc.gov/HAI/pdfs/guidelines/
ambulatory-care-checklist-07-2011.pdf
There are two sections to the checklist: I) Adminis-
tration Policies and Facility Practices, and II) Person-
nel and Patient-Care Observations. For the purpose 
of evaluating personnel competency and adherence 
to recommended infection prevention practices, on-
cology facilities should use Section II of the check-
list (i.e, Personnel and Patient-Care Observations) 
and modify and/or further supplement, as needed, 
to include specific practices and procedures relevant 
to their setting. These may include, but are not lim-
ited to, assessing personnel adherence to donning 
appropriate PPE and using aseptic technique (e.g., 
performing hand hygiene) when accessing central 
venous catheters.
Appendix	C.		
CDC Infection Prevention Checklist for Outpatient Settings
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and marrow transplant centers (a.k.a. bone 
marrow transplant or stem cell transplant 
centers)
	 •	 	Guidelines	 for	 Preventing	 Opportunistic	
Infections Among Hematopoietic Stem 




plications among Hematopoietic Cell 
Transplantation Recipients: A Global Per-
spective (available at: http://www.idsoci-
ety.org/uploadedFiles/IDSA/Guidelines-
Patient_Care/PDF_Library/OI.pdf) 
•	 	Occupational	 health	 requirements,	 includ-
ing bloodborne pathogen training, health-
care personnel immunizations, and recom-
mended personal protective equipment for 
handling antineoplastic agents and other 
hazardous drugs
	 •	 	Guideline	 for	 infection	control	 in	health-
care personnel (available at http://www.
cdc.gov/hicpac/pdf/InfectControl98.pdf)
	 •	 	Immunization	 of	 Health-Care	 Work-
ers: Recommendations of the Advisory 
Committee on Immunization (available 
at: http://www.cdc.gov/mmwr/preview/
mmwrhtml/00050577.htm)
	 •	 	OSHA	 Bloodborne	 Pathogens	 and	
Needlestick Prevention (available at: 
http://www.osha.gov/SLTC/bloodborne-
pathogens/index.html)
	 •	 	OSHA	 Controlling	 Occupational	 Expo-
sure to Hazardous Drugs (available at: 
http://www.osha.gov/dts/osta/otm/otm_
vi/otm_vi_2.html)
	 •	 	NIOSH	 List	 of	 Antineoplastic	 and	Other	
Hazardous Drugs in Healthcare Settings 
2010 (available at: http://www.cdc.gov/
niosh/docs/2010-167/pdfs/2010-167.pdf) 
	 •	 	NIOSH	 Personal	 Protective	 Equipment	
for Health Care Workers Who Work with 
Hazardous Drugs (available at: http://
www.cdc.gov/niosh/docs/wp-solu-
tions/2009-106/pdfs/2009-106.pdf) 
	 •	 	NIOSH	 Preventing	 Occupational	 Expo-
sure to Antineoplastic and Other Haz-




reconstituting, mixing, diluting, compound-
ing) of sterile medications, including anti-
neoplastic agents
	 •	 	United	 States	 Pharmacopeia	 Chapter	
<797>	 Guidebook	 to	 Pharmaceutical	
Compounding—Sterile Preparations
	 •	 	International	 Society	 of	Oncology	 Phar-




macists Guidelines for Handling Hazard-




treatment of patients with cancer, including 
appropriate antimicrobial prescribing prac-
tices and prechemotherapy assessment of 
neutropenia risk
	 •	 	National	Comprehensive	Cancer	Network	
Guidelines and Clinical Resources (avail-
able at: http://www.nccn.org/profession-
als/physician_gls/f_guidelines.asp)
	 •	 	American	 Society	 of	 Clinical	 Oncology	




Antimicrobial Agents in Neutropenic Pa-
tients with Cancer: 2010 Update by the 









To learn more about CDC’s new resources,  
please visit cdc.gov/cancer/preventinfections
